Method for the treatment or prevention of viral infection using nucleoside analogues
US6964968B2 · kind B2 · utility
2Cited by
11References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 31, 2003 |
| Grant date | Nov 15, 2005 |
| Priority date | — |
| Expiry date | Mar 31, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Viral infections selected from the group consisting of herpes simplex virus, varicella zoster virus, respiratory syncytial virus and cytomegalovirus can be treated by administering to the host a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof; wherein Y, Ra, and R1 are as defined herein. The compounds and salts can also be used to inhibit viral replication of these viruses in cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.